13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000048966
Total reported value
—
$2.9B
564 檔
46.5%
During the Q3 2024 filing period, Cowen And Company, LLC (CIK: 0000048966) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $2.9B across 564 reported positions.
During Q3 2024, Cowen And Company, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
Showing top 200 holdings (of 564 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NVDA | Nvidia CORP | Stock-Tech | 22.82% | — | +13.04% | |
| 2 | COIN | Coinbase Global Inc -class A | Stock-Financials | 7.65% | — | -14.35% | |
| 3 | META | Meta Platforms Inc-class A | Stock-Comm Services | 5.97% | — | -59.95% | |
| 4 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 4.93% | — | +86.99% | |
| 5 | MSFT | Microsoft CORP | Stock-Tech | 4.83% | — | +1138.30% | |
| 6 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 4.49% | — | -4.41% | |
| 7 | AAPL | Apple Inc | Stock-Tech | 4.14% | — | -38.72% | |
| 8 | LLY | Eli Lilly & Co | Stock-Healthcare | 4.04% | — | — | |
| 9 | TSLA | Tesla Inc | Stock-Consumer Disc | 2.72% | — | +28.89% | |
| 10 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 2.43% | — | — | |
| 11 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 2.42% | — | — | |
| 12 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 2.26% | — | +20.31% | |
| 13 | AMD | Advanced Micro Devices | Stock-Tech | 1.75% | — | -67.22% | |
| 14 | STOK | Stoke Therapeutics Inc | Stock-Other | 1.34% | — | -3.60% | |
| 15 | ✓ | Establishment Labs Holdings In | Stock-Other | 1.27% | — | -7.45% | |
| 16 | 8NI0 | Nikola CORP | Stock-Other | 1.15% | — | +301.70% | |
| 17 | ET | Energy Transfer LP | Stock-Energy | 1.03% | — | +3.83% | |
| 18 | ANSCW | Agriculture & Natural Solutions Acquisition Corporation | Stock-Other | 0.78% | — | +13.82% | |
| 19 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.77% | — | -14.43% | |
| 20 | MERC | Mercer International Inc | Stock-Other | 0.75% | — | — | |
| 21 | ARES | Ares Management Corporation | Stock-Financials | 0.72% | — | -40.66% | |
| 22 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 0.68% | — | — | |
| 23 | SMFG | Sumitomo Mitsui-spons Adr | Stock-Financials | 0.66% | — | -44.29% | |
| 24 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 0.66% | — | — | |
| 25 | STHO | Star Holdings | Stock-Other | 0.62% | — | +0.36% | |
| 26 | CCIX | Churchill Capital Corp IX | Stock-Other | 0.61% | — | +187.98% | |
| 27 | HTZWW | Hertz Global Hldgs Inc -cw51 | Stock-Other | 0.55% | — | +106.32% | |
| 28 | ✓ | Inflection Pt Acquisitn Crp | Stock-Other | 0.53% | — | +257.49% | |
| 29 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.52% | — | -71.16% | |
| 30 | VOYG | Voyager Technologies, Inc. | Stock-Other | 0.44% | — | — | |
| 31 | YCY-UN | AA Mission Acquisition Corp. II | Stock-Other | 0.41% | — | — | |
| 32 | NBR | Nabors Industries Ltd. | Stock-Other | 0.39% | — | +68.14% | |
| 33 | SVACW | Spring Valley Acquisition Corp. III | Stock-Other | 0.38% | — | +146.91% | |
| 34 | PAII | Pyrophyte Acquisition Corp. II | Stock-Other | 0.38% | — | +1.03% | |
| 35 | ✓ | Vine Hill Cap Invt CORP. | Stock-Other | 0.35% | — | — | |
| 36 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 0.34% | — | +173.94% | |
| 37 | CHTR | Charter Communications Inc-a | Stock-Comm Services | 0.31% | — | — | |
| 38 | ✓ | Alchemy Invts Acquisitn CORP | Stock-Other | 0.30% | — | +135.79% | |
| 39 | CHPT | ChargePoint Holdings, Inc. | Stock-Other | 0.30% | — | +24.00% | |
| 40 | ✓ | Keen Vision Acquisition CORP | Stock-Other | 0.29% | — | -26.05% | |
| 41 | ✓ | Gigcapital7 CORP | Stock-Other | 0.27% | — | — | |
| 42 | AGREUR | Avangrid Inc | Stock-Other | 0.26% | — | +165.63% | |
| 43 | TAK | Takeda Pharmaceutic-sp Adr | Stock-Healthcare | 0.25% | — | — | |
| 44 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 0.24% | — | — | |
| 45 | SIMA | SIM Acquisition Corp. I | Stock-Other | 0.23% | — | — | |
| 46 | ✓ | Hcm Ii Acquisition CORP | Stock-Other | 0.22% | — | — | |
| 47 | MCAHR | Mountain Crest Acquisition 6 Corp. | Stock-Other | 0.22% | — | +101.32% | |
| 48 | ESHA | Esh Acquisition Corp-a | Stock-Other | 0.22% | — | +280.18% | |
| 49 | TDS | Telephone And Data Systems | Stock-Comm Services | 0.21% | — | -7.25% | |
| 50 | ACI | Albertsons Cos Inc - Class A | Stock-Consumer Staples | 0.21% | — | +140.06% |
According to official SEC Form 13F filings, Cowen And Company, LLC reported a total U.S. public equity portfolio value of $2.9B across 564 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NVDA, COIN, META) accounted for 46.5% of total reported equity market value during Q3 2024.
During Q3 2024, Cowen And Company, LLC's top holdings by market value included NVDA (22.8%)、COIN (7.7%)、META (6.0%). The largest single position, NVDA, represented 22.8% of total portfolio value.
In Q3 2024, Cowen And Company, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.